What is the normal tricuspid annular plane systolic excursion (TAPSE) on echocardiography for a 40‑day‑old infant born at 32 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal TAPSE in a 40-Day-Old Former Preterm Infant (32 Weeks Gestation)

For a 40-day-old infant born at 32 weeks gestation, the normal TAPSE range is 8–11 mm, with values >8 mm considered normal for term neonates according to international guidelines 1.

Understanding the Context

Your patient is now approximately 37-38 weeks corrected gestational age (32 weeks at birth + ~5-6 weeks postnatal age). This places the infant in a transitional zone between preterm and term reference values.

Specific Reference Values

Guideline-Based Recommendations

The 2020 ESPNIC international evidence-based POCUS guidelines provide clear normative values 1:

  • Term neonates: TAPSE >8 mm (range 8–11 mm)
  • Children (general): TAPSE >12 mm (range 12–17 mm)
  • Measurement technique: Apical 4-chamber view, measuring systolic excursion of lateral (or medial) tricuspid annulus toward apex

Research-Derived Precision

A 2011 prospective study of 258 preterm and term neonates provides more granular data 2:

  • At 32 weeks gestation: Mean TAPSE approximately 0.70 cm (7.0 mm), with Z-score ±2 ranging from approximately 0.52–0.88 cm (5.2–8.8 mm)
  • At 37-38 weeks corrected age: Mean TAPSE approximately 0.90–0.95 cm (9.0–9.5 mm)
  • Linear progression: TAPSE increases linearly from 26 to 41 weeks gestation
  • Strong correlation: Pearson's correlation coefficient of 0.93 between gestational age and TAPSE (p<0.001)

Clinical Application Algorithm

For your 40-day-old former 32-weeker:

  1. Use corrected gestational age (approximately 37-38 weeks) as the primary reference point
  2. Expected TAPSE: 9–10 mm (based on corrected age)
  3. Minimum acceptable: >8 mm (guideline threshold for term neonates)
  4. Concerning if: <8 mm, which may indicate RV systolic dysfunction

Important Caveats

Measurement Considerations

  • No sex difference: TAPSE values show no statistically significant difference between male and female neonates (p=0.987) 2
  • High reproducibility: Intraobserver reliability 96%, interobserver agreement 92% 3
  • Z-scores preferred: When available, use Z-score calculations rather than absolute values for more precise assessment 1

Clinical Context Matters

The 2024 European Association of Cardiovascular Imaging guidelines emphasize that TAPSE should be interpreted alongside other RV functional parameters (fractional area change, RV output) due to inherent limitations of 2D echocardiography in assessing the complex RV geometry 4. However, TAPSE remains a recommended basic functional parameter for routine assessment.

Common Pitfalls to Avoid

  • Don't use adult values: Adult TAPSE >17 mm is completely inappropriate for neonates
  • Don't ignore prematurity: A 40-day-old former 32-weeker is physiologically different from a term 40-day-old
  • Don't rely solely on TAPSE: Consider it within the broader hemodynamic assessment, especially if evaluating for pulmonary hypertension or patent ductus arteriosus 1

Practical Interpretation

Values >8 mm: Normal RV systolic function
Values 6–8 mm: Borderline; correlate with clinical status and other echo parameters
Values <6 mm: Abnormal; suggests RV dysfunction requiring further evaluation

The measurement is particularly valuable in this population for assessing patent ductus arteriosus hemodynamics and detecting early pulmonary hypertension, both relevant concerns in former preterm infants 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.